These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24351527)

  • 1. Postinjury hyperfibrinogenemia compromises efficacy of heparin-based venous thromboembolism prophylaxis.
    Harr JN; Moore EE; Chin TL; Ghasabyan A; Gonzalez E; Wohlauer MV; Sauaia A; Banerjee A; Silliman CC
    Shock; 2014 Jan; 41(1):33-9. PubMed ID: 24351527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets are dominant contributors to hypercoagulability after injury.
    Harr JN; Moore EE; Chin TL; Ghasabyan A; Gonzalez E; Wohlauer MV; Banerjee A; Silliman CC; Sauaia A
    J Trauma Acute Care Surg; 2013 Mar; 74(3):756-62; discussion 762-5. PubMed ID: 23425732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability and other risk factors in trauma intensive care unit patients with venous thromboembolism.
    Van Haren RM; Valle EJ; Thorson CM; Jouria JM; Busko AM; Guarch GA; Namias N; Livingstone AS; Proctor KG
    J Trauma Acute Care Surg; 2014 Feb; 76(2):443-9. PubMed ID: 24398771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National Analysis of Outcomes for Adult Trauma Patients With Isolated Severe Blunt Traumatic Brain Injury Following Venous Thromboembolism Prophylaxis.
    Elkbuli A; Watts E; Patel H; Chin B; Wright DD; Inouye M; Nunez D; Rhodes HX
    J Surg Res; 2024 Aug; 300():165-172. PubMed ID: 38815515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional fibrinogen assay indicates that fibrinogen is critical in correcting abnormal clot strength following trauma.
    Harr JN; Moore EE; Ghasabyan A; Chin TL; Sauaia A; Banerjee A; Silliman CC
    Shock; 2013 Jan; 39(1):45-9. PubMed ID: 23247121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onset of Coagulation Function Recovery Is Delayed in Severely Injured Trauma Patients with Venous Thromboembolism.
    McCully BH; Connelly CR; Fair KA; Holcomb JB; Fox EE; Wade CE; Bulger EM; Schreiber MA;
    J Am Coll Surg; 2017 Jul; 225(1):42-51. PubMed ID: 28315812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.
    Regner JL; Shaver CN;
    Am J Surg; 2019 Jun; 217(6):1030-1036. PubMed ID: 30503515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic coagulability after injury: Is delaying venous thromboembolism chemoprophylaxis worth the wait?
    Sumislawski JJ; Kornblith LZ; Conroy AS; Callcut RA; Cohen MJ
    J Trauma Acute Care Surg; 2018 Nov; 85(5):907-914. PubMed ID: 30124623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombelastography-Based Dosing of Enoxaparin for Thromboprophylaxis in Trauma and Surgical Patients: A Randomized Clinical Trial.
    Connelly CR; Van PY; Hart KD; Louis SG; Fair KA; Erickson AS; Rick EA; Simeon EC; Bulger EM; Arbabi S; Holcomb JB; Moore LJ; Schreiber MA
    JAMA Surg; 2016 Oct; 151(10):e162069. PubMed ID: 27487253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of unfractionated heparin and low molecular weight heparin on the clotting of platelet-reduced whole blood: an in-vitro study utilizing thromboelastography.
    Chung J; Stevic I; Gantioqui J; Atkinson H; Chan AKC; Chan HHW
    Blood Coagul Fibrinolysis; 2021 Jul; 32(5):305-311. PubMed ID: 34231501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin versus enoxaparin for prevention of venous thromboembolism after trauma: A randomized noninferiority trial.
    Olson EJ; Bandle J; Calvo RY; Shackford SR; Dunne CE; Van Gent JM; Zander AL; Sikand H; Bongiovanni MS; Sise MJ; Sise CB
    J Trauma Acute Care Surg; 2015 Dec; 79(6):961-8; discussion 968-9. PubMed ID: 26317819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients.
    Stattin K; Lipcsey M; Andersson H; Pontén E; Bülow Anderberg S; Gradin A; Larsson A; Lubenow N; von Seth M; Rubertsson S; Hultström M; Frithiof R
    J Crit Care; 2020 Dec; 60():249-252. PubMed ID: 32920503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Is monitoring of anti-factor Xa levels required for low molecular weight heparin prophylaxis of venous thromboembolism in critically ill patients?].
    Ding M; Ning Y; Song L; Li P; Xie F; Li S; Wang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 May; 36(5):461-464. PubMed ID: 38845490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Xa-guided enoxaparin thromboprophylaxis reduces rate of deep venous thromboembolism in high-risk trauma patients.
    Singer GA; Riggi G; Karcutskie CA; Vaghaiwalla TM; Lieberman HM; Ginzburg E; Namias N; Lineen EB
    J Trauma Acute Care Surg; 2016 Dec; 81(6):1101-1108. PubMed ID: 27488490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Enoxaparin Dosing for Venous Thromboembolism Prophylaxis in General Trauma Patients.
    Walker CK; Sandmann EA; Horyna TJ; Gales MA
    Ann Pharmacother; 2017 Apr; 51(4):323-331. PubMed ID: 28228055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism chemoprophylaxis regimens in trauma and surgery patients with obesity: A systematic review.
    Shaikh S; Boneva D; Hai S; McKenney M; Elkbuli A
    J Trauma Acute Care Surg; 2020 Apr; 88(4):522-535. PubMed ID: 31688792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.